Firms

Catalyze Capital

Catalyze Capital

catalyze-capital.com

Catalyze Capital is an Amsterdam-based venture investor backing European early-stage and academic spin-off companies in life sciences, sustainable technologies and deep tech. It invests at seed and Series A and helps founders with commercial strategy, intellectual property, licensing, follow-on financing and access to non-dilutive funding. The fund operates within Catalyze Group and works with its innovation consultancy on sourcing, due diligence and portfolio support. Its investments include AI-assisted epilepsy monitoring, retinal drug development and precision-fermentation fats.

Founded
2024
Type
Venture capital

Funds1

  • Catalyze Capital—

    Closed-end venture fund investing in 10–15 early-stage European life-science, sustainable-technology and deep-tech companies. The first close was announced April 2, 2024. The announcement set a EUR 25 million final-close target and planned EUR 500,000–1.5 million investment tickets; it did not disclose the first-close amount or confirm a later final close.

Team

Operations and support

Benjamin SietersInvestment Director
Jalal Es-SbaiInvestment Partner
Marlene VéghCatalyze Group Chief Executive Officer
Max van ZandvoortInvestment Analyst
Myriam KeijzerCatalyze Group Chief People Officer
Peter SchoeversManaging Partner
Theodoor RutgersInvestment Partner
Tim VinkChief Financial Officer

Co-investing

Investments